ImmunoPrecise Antibodies IPA is set to give its latest quarterly earnings report on Tuesday, 2024-12-10. Here's what investors need to know before the announcement.
Analysts estimate that ImmunoPrecise Antibodies will report an earnings per share (EPS) of $-0.07.
Investors in ImmunoPrecise Antibodies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings Track Record
During the last quarter, the company reported an EPS missed by $0.03, leading to a 6.85% increase in the share price on the subsequent day.
Here's a look at ImmunoPrecise Antibodies's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.08 | -0.07 | -0.100 |
| EPS Actual | -0.11 | -0.58 | -0.08 | -0.074 |
| Price Change % | 7.000000000000001% | 0.0% | -9.0% | -5.0% |
Market Performance of ImmunoPrecise Antibodies's Stock
Shares of ImmunoPrecise Antibodies were trading at $0.3801 as of December 06. Over the last 52-week period, shares are down 62.61%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
